26 Jan 2023
39m

Two-Year Biotech Bloodbath, Poorly Constructed Phase 2B Trials and 2023 Predictions with Eden Rahim, Portfolio Manager for the Next Edge Biotech and Life Sciences Opportunities Fund

Podcast cover

Planet MicroCap Podcast | MicroCap Investing Strategies

Open in Podwise to generate AI notes

Sign in to process this episode and unlock summaries, transcripts, highlights and translations.

Open in Podwise

Shownotes are not generated by Podwise.

Two-Year Biotech Bloodbath, Poorly Constructed Phase 2B Trials and 2023 Predictions with Eden Rahim, Portfolio Manager for the Next Edge Biotech and Life Sciences Opportunities Fund